BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Business

  Cardiovascular Systems Names a New CFO, Effective Immediately

  Points succeeds Larry Betterley as CFO and will report to Scott Ward, Chairman, President and CEO.

  February 7, 2018

   · 

  4 min read
• Business

  Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2017

  Enanta’s cash, cash equivalents and short-term and long-term marketable securities totaled $297.5 million at December 31, 2017.

  February 7, 2018

   · 

  11 min read
• Genetown

  Sage Therapeutics Announces Proposed Public Offering of $575 Million of its Common Stock

  Sage Therapeutics today announced that it has commenced an underwritten public offering of $575.0 million of its common stock.

  February 7, 2018

   · 

  4 min read
• Pharm Country

  Cold Spring Harbor Laboratory Release: Autism Genetics Study Calls Attention to Impaired Motor Skills, General Cognitive Impairment

  A new study of genetic factors involved causing autism spectrum disorders draws fresh attention to the impact these illnesses have on motor skills, and more broadly on cognitive function.

  February 7, 2018

   · 

  2 min read
• Business

  Sosei Provides an Update on Its Immuno-Oncology Clinical Program with AstraZeneca

  The first patient has been dosed in an expansion cohort in the Phase 1b segment of the Phase 1 study in advanced solid tumours.

  February 7, 2018

   · 

  5 min read
• Genetown

  Syros Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

  Syros today announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 628,272 shares at the public offering price of $9.55 per share.

  February 7, 2018

   · 

  4 min read
• Business

  Lannett Announces Fiscal 2018 Second-Quarter Financial Results; Reports Record Revenues, Strong Earnings

  Lannett today reported financial results for its fiscal 2018 second quarter ended December 31, 2017.

  February 7, 2018

   · 

  65 min read
• 

  Cancer Biotech Novocure Scores New $150M Debt Financing

  The cash will be used to to execute core strategies of driving commercial adoption of Optune and advancing the clinical pipeline.

  February 7, 2018

   · 

  3 min read
• Business

  ViewRay Appoints Scott Huennekens and Daniel Moore to its Board of Directors

  The Company also announced the impending resignations of two directors: David Bonita, M.D., and Mark S. Gold, M.D. Both Dr. Bonita and Dr. Gold announced their intention to step down from the Board at the Company’s Annual Meeting.

  February 7, 2018

   · 

  4 min read
• Business

  InfuSystem Holdings Reports Interim CFO Will Leave Company at End of Current Quarter

  Mr. Downs resignation does not reflect any dispute or disagreement with the Company, nor does it relate to any issues with respect to the Company’s financial performance.

  February 7, 2018

   · 

  4 min read